SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-055066
Filing Date
2021-11-08
Accepted
2021-11-08 08:04:18
Documents
15
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kdny-8k_20211108.htm   iXBRL 8-K 39384
2 EX-99.1 kdny-ex991_6.htm EX-99.1 319072
3 GRAPHIC gexqbfv3v5j4000001.jpg GRAPHIC 67035
  Complete submission text file 0001564590-21-055066.txt   627978

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kdny-20211108.xsd EX-101.SCH 5937
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kdny-20211108_def.xml EX-101.DEF 13382
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20211108_lab.xml EX-101.LAB 23017
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20211108_pre.xml EX-101.PRE 14111
8 EXTRACTED XBRL INSTANCE DOCUMENT kdny-8k_20211108_htm.xml XML 5172
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 211386576
SIC: 2834 Pharmaceutical Preparations